During an attempt to purify the peroxisomal acyl-CoA oxidases -for the dehydrogenase. (3) The substrate spectrum of the oxidase from human liver and kidney, we discovered a novel short-chain was comparable with that described for the dehydrogenase. (4) acyl-CoA oxidase, which was well separated from the known On column chromatography, the oxidase and dehydrogenase peroxisomal oxidases on various chromatographic columns.
INTRODUCTION
The first step of fatty acid fl-oxidation is the desaturation of an acyl-CoA to a 2-trans-enoyl-CoA. In mitochondria this step is catalysed by an FAD-containing acyl-CoA dehydrogenase (for reviews, see [1, 2] ). The electrons resulting from the reaction are transferred from FAD to the electron-transferring flavoprotein, another FAD-containing protein, which donates electrons to the respiratory chain. Rat liver mitochondria contain four (short-, medium-, long-and very-long-chain) acyl-CoA dehydrogenases [3] [4] [5] [6] [7] [8] that act on straight-chain acyl-CoAs and two (2-methylbranched-chain acyl-CoA and isovaleryl-CoA) dehydrogenases that act on branched-chain acyl-CoAs. In peroxisomes the first step of fl-oxidation is catalysed by an FAD-containing acyl-CoA oxidase [9, 10] that transfers electrons directly to molecular oxygen, yielding H202, which is disposed of by another peroxisomal enzyme, catalase. Rat liver peroxisomes contain three acyl-CoA oxidases [1 1-13] : (1) an enzyme that oxidizes the CoA esters of medium-, long-and very-long-chain fatty acids and that is inducible by treatment of the animals with peroxisome proliferators (palmitoyl-CoA oxidase); (2) an enzyme that oxidizes the CoA esters of 2-methyl-branched-chain fatty acids and that is not inducible (pristanoyl-CoA oxidase); and (3) another non-inducible enzyme that oxidizes the CoA esters of the bile acid intermediates di-and tri-hydroxycoprostanic acids (trihydroxycoprostanoyl-CoA oxidase). The last enzyme is not found in extrahepatic tissues.
Human liver peroxisomes are also capable of oxidizing palmitoyl-CoA, pristanoyl-CoA and trihydroxycoprostanoylCoA [14, 15] . As in-the rat, palmitoyl-CoA and trihydroxycoprostanoyl-CoA are oxidized by separate enzymes [141 In order to establish the presence of a separate acyl-CoA oxidase for 2-methyl-branched-chain fatty acids in human tissues, and in order to define the substrate specificities of the different human acyl-CoA oxidases, we separated human liver and kidney oxidases on various columns and measured the acyl-CoA oxidase activities in the eluates, using a variety of CoA esters as the substrates. Much to our surprise, we found during these experiments that an important portion of the short-chain acyl-CoA oxidase activity did not co-elute with the activities of palmitoylCoA oxidase, pristanoyl-CoA oxidase or trihydroxycoprostanoyl-CoA oxidase, suggesting that human tissues contain a separate short-chain acyl-CoA oxidase. However, purification of the enzyme and determination of its subcellular localization and substrate specificity demonstrated that the novel oxidase is identical with the mitochondrial short-chain acyl-CoA dehydrogenase, which in the absence of a suitable electron acceptor functions as an oxidase. 
EXPERIMENTAL

Preparation of homogenates and subceilular fractions
Human liver and kidney were obtained after partial hepatectomy or total nephrectomy for liver and kidney tumours respectively. All donors were adults. Approval was granted by the Institutional Ethics Committee. For enzyme purification, tissues were divided in small portions and stored at -80°C until use. For subcellularfractionation experiments, fresh liver and kidney were homogenized in 0.25 M sucrose/0. % (v/v) ethanol/I mM EDTA, pH-7.2, and the homogenates were fractionated into nuclear (N), heavy mitochondrial (M), light mitochondrial (L), microsomal (P) and cytosolic (S) fractions as described before for rat liver [18] . The M-fraction, enriched in mitochondria and the Lfraction, enriched in peroxisomes, were subfractionated by isopycnic centrifugation in an iso-osmotic self-generating Percoll gradient [19] .
Determination of marker enzymes and proteins
Marker enzymes (glutamate dehydrogenase, catalase, lactate dehydrogenase, acid phosphatase, glucose-6-phosphatase) and protein were determined as described previously [19] .
Acyl-CoA oxidase measurements
Substrate-dependent H202 production in homogenates and subcellular fractions was measured by means ofperoxidase-catalysed homovanillic acid dimerization [20, 21] [3, 6, 7] . The incubation medium contained 0.1 M potassium phosphate buffer, pH 8.0, 1.5 mM PMS, 0.048 mM DCIP, 0.1 mM FAD and 0.1 mM acyl-CoA. The final volume was 0.5 ml. After preincubation of the enzyme in FAD-containing buffer for 5 min at 30°C, PMS and DCIP were added and the reaction was started by addition of substrate. The reaction was carried out at 32°C and bleaching of DCIP was followed at 600 nm.
Partial purification of human acyl-CoA oxidases Human liver and kidney acyl-CoA oxidases were partially purified by heat treatment and (NH4)2'SO4 fractionation as described previously for rat liver [12] .
Chromatographic separations
Protein chromatography was done on a Waters 600 system equipped with Teflon and PEEK tubing. The following columns were used: Protein PAK Glass HIC phenyl-5PW (8.0 mm x 75.0 mm) and DEAE-5PW (8.0 mm x 75.0 mm) (Nihon Waters Ltd., Tokyo, Japan), HiLoad Superdex 200 prep grade (1.6 cm x 60 cm) (Pharmacia Belga, Brussels, Belgium), and hydroxyapatite Bio-Gel HPHT (100 mm x 7.8 mm) (BioRad, Richmond, CA, U.S.A.).
For hydrophobic chromatography on the phenyl column, a sample of the partially purified acyl-CoA oxidase preparation was thawed, diluted twice in 20 mM potassium phosphate buffer (pH 7.5)/0.6 M (NH4)2SO4/10 ,uM FAD and dialysed overnight against the same buffer (buffer A). After centrifugation to remove undissolved material, a sample of the supernatant was injected on to the phenyl column, equilibrated in the same buffer, and the column was eluted at a flow rate of 0.8 ml/min. Bound proteins were eluted with a linear negative salt and positive ethylene glycol gradient [100-0 % buffer A; 0-100 % buffer B, containing 20 mM potassium phosphate, pH 7.5, 25 % (w/v) ethylene glycol and 10 1sM FAD] over 45 min. Fractions (1.6 ml) were collected and analysed for conductivity and acyl-CoA oxidase activity, and their A280 was monitored. Fractions from the phenyl column containing the short-chain acyl-CoA oxidase activity were pooled, 0.1 vol. of 1 M potassium phosphate buffer, pH 8, was added, and the solution was adjusted to 50 % (NH4)2504 saturation. After centrifugation, the pellet was dissolved in 200 mM potassium phosphate buffer, pH 7.5, containing 10% ethylene glycol and 10 uM FAD, and dialysed overnight against the same buffer. The undissolved material was removed by centrifugation, and a sample of the supernatant was subjected to gel filtration on a HiLoad Superdex 200 column, equilibrated in the same buffer, and eluted at a flow rate of 1 ml/min. The A280 was monitored. Fractions (2 ml) were collected and assayed for acyl-CoA oxidase activity. The fractions from the gel-filtration column containing the highest short-chain acyl-CoA oxidase activity were pooled and concentrated by (NH4)2SO4 precipitation. After centrifugation, the pellet was dissolved in 5 mM potassium phosphate buffer (pH 7.2)/1 mM EDTA (separation of the oxidases is better in the presence of EDTA)/O1,uM FAD/1O % ethylene glycol, and dialysed overnight against the same buffer. The undissolved material was removed by centri-fugation, and a portion of the supernatant was injected on to a hydroxyapatite column, equilibrated in the same phosphate buffer. After a wash of 5 min, the adsorbed oxidases were eluted with a phosphate gradient, increasing linearly from 5 to 200 mM potassium phosphate, pH 7.2, in the presence of 1 mM EDTA, 10 ,uM FAD and 10% ethylene glycol for 60 min. Elution rate was 0.6 ml/min; 1.8 ml fractions were collected and assayed for acyl-CoA oxidase activity and Pi, and their A280 was monitored.
The fractions from the hydroxyapatite column containing the highest activity of short-chain acyl-CoA oxidase were pooled and dialysed against 20 mM Tris/HCl buffer, pH 8.6, containing 20% (w/v) glycerol. A portion was injected on to a DEAE column, equilibrated in the same buffer, and the column was eluted at a flow rate of 1 ml/min. Bound proteins were eluted with a linear pH/salt gradient (0-100 % buffer containing 20 mM Tris/HCl, pH 7.8, 0.25 M NaCl and 20 % glycerol) over 40 min. Fractions (2 ml) were collected in tubes containing 20 ,1 of 1 mM FAD. The fractions were monitored at 210 nm, and analysed for acyl-CoA oxidase activity and conductivity.
SOS/PAGE Electrophoresis in 10-20 % (w/v) acrylamide gradient gels was done as described previously [11] . Gels were silver-stained as described by Guevara et al. [22] .
could also be separated from palmitoyl-CoA oxidase, pristanoylCoA oxidase and trihydroxycoprostanoyl-CoA oxidase on hydroxyapatite and gel-filtration columns (results not shown). A similar separation of a portion of the hexanoyl-CoA oxidase activity from the other oxidase activities was obtained after chromatography of partially purified oxidase preparations from kidney (results not shown). Surprisingly, the latter preparations also contained significant trihydroxycoprostanoyl-CoA oxidase activity. In the rat, trihydroxycoprostanoyl-CoA oxidase activity cannot be detected in kidney or other extrahepatic tissues [12] . 
RESULTS
Presence of a separate short-chain acyl-CoA oxidase in human liver and kidney
In order to establish the presence of several acyl-CoA oxidases with different substrate specificities in human tissues, we partially purified the oxidases from human liver and kidney by (NH4)2SO4 fractionation and heat treatment. In a first screening, the partially purified preparations were loaded on various columns and the eluates were analysed for acyl-CoA oxidase activity with several acyl-CoA esters as the substrates. As an example, Figure 1 shows the elution pattern after hydrophobic chromatography of a partially purified oxidase preparation from liver on a phenyl column. 2-Methylpalmitoyl-CoA oxidase, which is identical with pristanoyl-CoA oxidase [12] , was eluted in a single peak. Trihydroxycoprostanoyl-CoA oxidase co-eluted, as a single peak, with 2-methylpalmitoyl-CoA oxidase. Palmitoyl-CoA oxidase activity was eluted in a broad peak showing a shoulder that coincided with the fractions containing the highest 2-methylpalmitoyl-CoA oxidase and trihydroxycoprostanoyl-CoA oxidase activities. This result suggests that in the human, as in the rat [12, 13] , palmitoyl-CoA is oxidized by two enzymes: palmitoylCoA oxidase (peak) and pristanoyl-CoA oxidase (shoulder). Hexanoyl-CoA oxidase was eluted in three peaks: a first peak that was well separated from the palmitoyl-CoA oxidase, 2-methylpalmitoyl-CoA oxidase and trihydroxycoprostanoyl-CoA oxidase peaks; a second peak that co-eluted with the palmitoylCoA oxidase peak; and a third peak that co-eluted with the 2-methylpalmitoyl-CoA oxidase/trihydroxycoprostanoyl-CoA oxidase peak. These results suggest that (1) a separate shortchain acyl-CoA oxidase might exist in the human (first peak); (2) as is the case for rat palmitoyl-CoA oxidase (13), human palmitoyl-CoA oxidase shows some activity with hexanoyl-CoA (second peak); and (3) human pristanoyl-CoA oxidase is also slightly active towards hexanoyl-CoA (third peak); the last is not true for rat pristanoyl-CoA oxidase [13] . A significant portion of the hexanoyl-CoA oxidase activity Figure) and hexanoyl-CoA oxidase activity (0; recovery 25%). Figure 1 ) containing the short-chain acyl-CoA oxidase were pooled and acyl-CoA oxidase activity was measured on the pooled fractions with the-CoA esters listed in the (Figure 1 ). The fractions of the first hexanoyl-CoA oxidase peak were pooled, concentrated and subjected to gel filtration (results not shown). The molecular mass of the enzyme was estimated at 189 + 5 kDa (mean + S.E.M. for 4 experiments). The active fractions from the gel-filtration column were pooled, concentrated and applied to a hydroxyapatite column (results not shown). Finally, the active fractions from the hydroxyapatite column were pooled and loaded on a DEAE anion-exchange column (Figure 2) . The fractions eluted from the hydroxyapatite and DEAE columns were also analysed by SDS/PAGE (Figure 3) . In, the fractions-of highest purity only one major band with a molecular mass of 43 kDa was visible. Similar results were obtained for the short-chain acyl-CoA oxidase from kidney (results not shown).
The hexanoyl-CoA oxidase activities found in the second and third peaks from the phenyl column (Figure 1 ) invariably coeluted from the columns (gel filtration, hydroxyapatite, DEAE) with palmitoyl-CoA oxidase and with pristanoyl-CoA oxidase respectively, confirming that these activities are side activities of palmitoyl-CoA oxidase and pristanoyl-CoA oxidase (results not shown).
Substrate-dependence and specffrcity of short-chain. acyl-CoA oxidase The substrate-dependence and specificity of the short-chain acylCoA oxidase were investigated in the pooled fractions containing the first hexanoyl-CoA oxidase peak from a phenyl column (see Figure 1 ).
Substrate-dependence was determined with hexanoyl-CoA as the substrate. After linear transformation of the curve in accordance with Lineweaver-Burk, an apparent Km of 130 ,uM was calculated. Addition of albumin to the assay mixtures did not influence the kinetic parameters (results not shown).
The substrate specificity of the enzyme is shown in Table 1 . The enzyme was most active towards hexanoyl-CoA and valerylCoA (C5). Significant activity was also found with butyryl-CoA, heptanoyl-CoA, and the branched 2-methylhexanoyl-CoA. No or only insignificant activities were observed with the CoA esters of medium-(octanoic acid, decanoic acid) and long-(palmitic acid) chain fatty acids, short-chain dicarboxylic fatty acids (glutaric acid, C5), the 2-methyl-branched isobutyric acid and the 3-methyl-branched isovaleric acid.
Subcellular distribution of hexanoyl-CoA oxidase
In the conviction that we had discovered a novel peroxisomal short-chain acyl-CoA oxidase, we wished to confirm the enzyme's peroxisomal localization by subcellular-fractionation experiments. Therefore, a kidney homogenate was fractionated by differential centrifugation in fractions enriched in nuclei, mitochondria (heavy mitochondrial fraction), peroxisomes and lyso- Figure  5 shows the results obtained with the heavy mitochondrial fraction. Hexanoyl-CoA oxidase activity followed a bimodal distribution, but most of its activity coincided with that of the mitochondrial marker glutamate dehydrogenase, indicating a predominantly mitochondrial localization of the hexan&yl-CoA oxidase activity present in the heavy mitochondrial fraction. In contrast, palmitoyl-CoA oxidase was present almost completely in the catalase-containing gradient fractions. When the light mitochondrial fraction was subfractionated on a self-generating Percoll gradient, most of the hexanoyl-CoA oxidase activity was present in the fractions containing catalase and palmitoyl-CoA oxidase, and only a smaller part was present in the fractions containing glutamate dehydrogenase, demonstrating that the hexanoyl-CoA oxidase activity present in the light mitochondrial fraction is mostly peroxisomal (results not shown).
The hexanoyi-COA oxidase activity present In the heavy mitochondrlal fraction Is due to the mitochondrial short-chain acyl-CoA dehydrogenase
Since the molecular mass (the native enzyme and its subunit) and the substrate specificity of our purified short-chain acyl-CoA oxidase agreed reasonably well with those of the short-chain acyl-CoA dehydrogenase reported by Finocchiaro et al. [7] , we assumed that the mitochondrial hexanoyl-CoA oxidase activity was due to the short-chain acyl-CoA dehydrogenase and that the peroxisomal hexanoyl-CoA oxidase activity was a side activity of palmitoyl-CoA and pristanoyl-CoA oxidase. In order to prove this hypothesis, a liver homogenate was fractionated by differential centrifugation in fractions enriched in nuclei, mitochondria (heavy mitochondrial fraction), peroxisomes and lysosomes (light mitochondrial fraction), endoplasmic reticulum, and soluble components.
The heavy mitochondrial fraction was subjected to freezethawing and sonication followed by centrifugation, and the supernatant containing the released matrix proteins was loaded on a phenyl column. The column fractions were analysed for hexanoyl-CoA oxidase and hexanoyl-CoA dehydrogenase activity ( Figure 6 ). Hexanoyl-CoA oxidase was eluted, as a single peak, in the region where the purified short-chain acyl-CoA oxidase was expected to be eluted, and virtually no activity was found in the region where the peroxisomal acyl-CoA oxidases are normally eluted (see Figure 1) . The oxidase and dehydrogenase activities towards hexanoyl-CoA coincided, the dehydrogenase activity being approx. 20 times higher than the oxidase activity. The results indicate that (1) the purified acyl-CoA oxidase is of mitochondrial origin and (2) the oxidase activity is catalysed by the mitochondrial short-chain acyl-CoA dehydrogenase. Further evidence for these conclusions was obtained in the following experiments. The light mitochondrial fraction, prepared by differential centrifugation as described above, was subfractionated on a self-generating Percoll gradient (Figure 7) , the fractions containing the mitochondria (glutamate dehydrogenase) and those containing the peroxisomes (catalase, palmitoylCoA oxidase) were separately pooled, and the mitochondrial and peroxisomal matrix proteins were extracted by freeze-thawing and sonication in hypotonic buffer followed by centrifugation. The released mitochondrial and peroxisomal matrix proteins were chromatographed on a phenyl column in two separate runs, and the eluates were analysed for hexanoyl-CoA oxidase, palmitoyl-CoA oxidase and 2-methylpalmitoyl-CoA oxidase activities.
The combined results of these experiments again confirmed that the hexanoyl-CoA oxidase associated with the mitochondrial matrix proteins was eluted in the same fractions as the purified short-chain acyl-CoA oxidase (peak 1 of Figure 1 ) and the shortchain acyl-CoA dehydrogenase (see Figure 6 ), and that this separate short-chain acyl-CoA oxidase was absent from peroxisomal matrix proteins (results not shown).
Finally, a partially purified oxidase preparation from liver prepared by heat treatment and (NH4)2S04 fractionation was chromatographed on a phenyl column exactly as described for Figure 1 , and acyl-CoA dehydrogenase activities were measured on the pooled fractions of the first hexanoyl-CoA oxidase peak and on those of the second and third peaks (containing the palmitoyl-CoA oxidase and 2-methylpalmitoyl-CoA oxidase activities). In the pooled first hexanoyl-CoA oxidase peak, acyl-CoA dehydrogenase was most active towards valerylCoA (460 nmol/min per ml), followed by hexanoyl-CoA (343 nmol/min per ml), 2-methylhexanoyl-CoA (250 nmol/min per ml) and butyryl-CoA (150 nmol/min per ml). As expected for the short-chain acyl-CoA dehydrogenase, no activity could be observed towards the CoA esters of medium-(octanoic, decanoic) and long-(palmitic) chain fatty acids. No acyl-CoA dehydrogenase activity was found in the pooled second and third peaks, indicating that the hexanoyl-CoA oxidase activity associated with these fractions is a side activity of the peroxisomal palmitoyl-CoA and pristanoyl-CoA oxidases. (189 kDa), is somewhat higher than the value reported by the laboratory of Tanaka (168 kDa) [7] , we interpret the difference as being due to differences in experimental conditions. Our results mean that in the absence of suitable electron acceptors human short-chain acyl-CoA dehydrogenase is capable of transferring electrons directly to molecular oxygen, albeit at lower rates than the reduction rates of the electron acceptors. Mitochondria contain four acyl-CoA dehydrogenases involved in the oxidation of straight-chain acyl-CoAs and two acyl-CoA dehydrogenases involved in the oxidation of branched-chain acyl-CoAs (see the Introduction). It remains to be investigated whether the other acyl-CoA dehydrogenases are also capable of functioning as oxidases when the proper electron acceptors are lacking. The observations that the subcellular distribution of palmitoyl-CoA oxidase was clearly peroxisomal and that virtually no palmitoyl-CoA dehydrogenase activity could be detected in column fractions displaying palmitoyl-CoA oxidase activity (G. Vanhove, P. P. Van Veldhoven and G. P. Mannaerts, unpublished work) suggest that at least the long-and very-longchain acyl-CoA dehydrogenases, both ofwhich are active towards palmitoyl-CoA, do not, or only poorly, function as oxidases.
DISCUSSION
The question remains as to whether our observations are of purely academic interest or whether they might have physiological or pathophysiological significance. Perhaps there might be implications for the pathogenesis of reperfusion injury after cardiac ischaemia. Reperfusion injury to the myocardium is believed to be caused, at least in part, by reactive oxygen species, and high fatty acid levels aggravate this injury [24] . After cardiac ischaemia, the activity of the electron-transport chain, which accepts electrons from the acyl-CoA dehydrogenases via the electron-transferring protein, is decreased [25] . Is it possible that the short-chain acyl-CoA dehydrogenase, which is present not only in liver and kidney but in other tissues as well [26] , behaves as an oxidase under conditions of diminished electron-transport activity, thereby producing harmful amounts of H202?
Finally, during these studies the intriguing observation was made that trihydroxycoprostanoyl-CoA oxidase is present not only in human liver but also in human kidney. In the rat, trihydroxycoprostanoyl-CoA oxidase is absent from extrahepatic tissues. The significance of the enzyme's presence in human extrahepatic tissues is currently under study. 
